Skip to main content

Navigation group

Type at least 3 characters
1,210 articles

Articles

Original Research

Published on 17 Jun 2022

The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D3 Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer

in Cancer Endocrinology

  • Justine Vanhevel
  • Lieve Verlinden
  • Shauni Loopmans
  • Stefanie Doms
  • Iris Janssens
  • Sien Bevers
  • Steve Stegen
  • Hans Wildiers
  • Annemieke Verstuyf
The Combination of the CDK4/6 Inhibitor, Palbociclib, With the Vitamin D3 Analog, Inecalcitol, Has Potent In Vitro and In Vivo Anticancer Effects in Hormone-Sensitive Breast Cancer, But Has a More Limited Effect in Triple-Negative Breast Cancer
Frontiers in Endocrinology
doi 10.3389/fendo.2022.886238
  • 5,624 views
  • 4 citations

Original Research

Published on 31 May 2022

Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response

in Cancer Endocrinology

  • Camilla Cristalli
  • Maria Cristina Manara
  • Sergio Valente
  • Evelin Pellegrini
  • Alberto Bavelloni
  • Alessandra De Feo
  • William Blalock
  • Elisabetta Di Bello
  • David Piñeyro
  • Angelika Merkel
Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage Response
Frontiers in Endocrinology
doi 10.3389/fendo.2022.876602
  • 4,257 views
  • 9 citations